Integration microarray and regulation datasets for chronic obstructive pulmonary disease

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 14, 2013, Pages 1923-1931

  Yang, J Y ^a   Jin, J ^a   Zhang, Z ^a   Zhang, L ^a   Shen, C ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Gene regulatory networks; Pathway analysis

Indexed keywords

PROTEIN NFKB1; SMAD4 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; HUMAN; MICROARRAY ANALYSIS; PATHOGENESIS; REGULATORY MECHANISM; ALGORITHM; CYTOLOGY; FACTUAL DATABASE; GENE EXPRESSION REGULATION; GENETICS; LUNG LAVAGE; PHYSIOLOGY; SIGNAL TRANSDUCTION; SMOKING;

ALGORITHMS; BRONCHOALVEOLAR LAVAGE FLUID; DATABASES, FACTUAL; GENE EXPRESSION REGULATION; HUMANS; MICROARRAY ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTOR CROSS-TALK; SMOKING; TRANSCRIPTOME;

EID: 84884189410     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. MATHERS CD, LONCAR D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
2. DI STEFANO A, CARAMORI G, RICCIARDOLO FL, CAPELLI A, ADCOCK IM, DONNER CF. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy 2004; 34: 1156-1167.
3. BARNES PJ. Mechanisms in COPD: differences from asthma. Chest 2000; 117(2 Suppl: 10S-14S.
4. CHUNG K. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001; 18(34 suppl: 50s-59s.
5. MACNEE W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 258-266; discussion 90-91.
6. PAUWELS RA, RABE KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364(9434): 613-620.
7. CHEN ZH, KIM HP, RYTER SW, CHOI AM. Identifying targets for COPD treatment through gene expression analyses. Int J Chron Obstruct Pulmon Dis 2008; 3: 359-370.
8. BHATTACHARYA S, SRISUMA S, DEMEO DL, SHAPIRO SD, BUENO R, SILVERMAN EK, REILLY JJ, MARIANI TJ. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol 2009; 40: 359-367.
9. POLISKA S, CSANKY E, SZANTO A, SZATMARI I, MESKO B, SZELES L, DEZSO B, SCHOLTZ B, PODANI J, KILTY I, TAKACS L, NAGY L. Chronic Obstructive Pulmonary Disease-Specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function. Respiration 2011; 81: 499-510.
10. WACHI S, YONEDA K, WU R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 2005; 21: 4205-4208.
11. BRIVANLOU AH, DARNELL JE, JR. Signal transduction and the control of gene expression. Science 2002; 295(5556): 813-818.
12. WINGENDER E. The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform 2008; 9: 326.
13. JIANG C, XUAN Z, ZHAO F, ZHANG MQ. TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 2007; 35(Database issue: D137-140.
14. KANEHISA M. The KEGG database. Novartis Found Symp 2002; 247: 91-101; discussion -3, 19-28, 244-252.
15. SMYTH GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.
16. HUANG DA W, SHERMAN BT, LEMPICKI RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
17. SHANNON P, MARKIEL A, OZIER O, BALIGA NS, WANG JT, RAMAGE D, AMIN N, SCHWIKOWSKI B, IDEKER T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498-2504.
18. KESHAVA PRASAD T, GOEL R, KANDASAMY K, KEERTHIKUMAR S, KUMAR S, MATHIVANAN S, TELIKICHERLA D, RAJU R, SHAFREEN B, VENUGOPAL A, BALAKRISHNAN L, MARIMUTHU A, BANERJEE S, SOMANATHAN DS, SEBASTIAN A, RANI S, RAY S, HARRYS KISHORE CJ, KANTH S, AHMED M, KASHYAP MK, MOHMOOD R, RAMACHANDRA YL, KRISHNA V, RAHIMAN BA, MOHAN S, RANGANATHAN P, RAMABADRAN S, CHAERKADY R, PANDEY A. Human protein reference database-2009 update. Nucleic Acids Res 2009; 37(Database issue: D767-D772.
19. STARK C, BREITKREUTZ BJ, CHATR-ARYAMONTRI A, BOUCHER L, OUGHTRED R, LIVSTONE MS, NIXON J, VAN AUKEN K, WANG X, SHI X, REGULY T, RUST JM, WINTER A, DOLINSKI K, TYERS M. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res 2011; 39(Database issue: D698-D704.
20. LIU ZP, WANG Y, ZHANG XS, CHEN L. Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains. BMC Syst Biol 2010; 4(Suppl): S11
21. BAKKE PS, ZHU G, GULSVIK A, KONG X, AGUSTI AG, CALVERLEY PM, DONNER CF, LEVY RD, MAKE BJ, PARE PD, RENNARD SI, VESTBO J, WOUTERS EF, ANDERSON W, LOMAS DA, SILVERMAN EK, PILLAI SG. Candidate genes for COPD in two large data sets. Eur Respir J 2011; 37: 255-263.
22. BROWN V, ELBORN JS, BRADLEY J, ENNIS M. Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res 2009; 10: 24.
23. LUO BL, NIU RC, FENG JT, HU CP, XIE XY, MA LJ. Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-beta/Smads signaling pathways. Arch Med Res 2008; 39: 388-396.
24. NIU RC, LUO BL, FENG JT, WANG LJ, HU CP. Expression of secretory leukocyte proteinase inhibitor in the bronchi and lung tissues of chronic obstructive pulmonary disease rat models and the regulatory mechanism by transforming growth factor beta(1). Zhonghua Jie He He Hu Xi Za Zhi 2007; 30: 851-856.
25. QU P, ROBERTS J, LI Y, ALBRECHT M, CUMMINGS OW, EBLE JN, DU H, YAN C. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease. Lung Cancer 2009; 63: 341-347.
26. YAO H, YANG SR, EDIRISINGHE I, RAJENDRASOZHAN S, CAITO S, ADENUGA D, O'REILLY MA, RAHMAN I. Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice. Am J Respir Cell Mol Biol 2008; 39: 7-18.
27. HOGG JC, TIMENS W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009; 4: 435-459.
28. POLOSUKHIN VV, CATES JM, LAWSON WE, ZAYNAGETDINOV R, MILSTONE AP, MASSION PP, OCAK S, LEE JW, BOWLER RP, KONONOV AV, RANDELL SH, BLACKWELL TS. Bronchial secretory IgA deficiency correlates with airway inflammation and progression of COPD. Am J Respir Crit Care Med 2011; 184: 317-327.
29. VAN DER DEEN M, DE VRIES E, TIMENS W, SCHEPER RJ, TIMMER-BOSSCHA H, POSTMA DS. ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res 2005; 6: 59.
30. VAN DE SCHANS SA, JANSSEN-HEIJNEN ML, BIESMA B, SMEENK FW, VAN DE POLL-FRANSE LV, SEYNAEVE C, COEBERGH JW. COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient. Eur J Cancer 2007; 43: 2194-2202.
31. YAO H, RAHMAN I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol 2009; 9: 375-383.
32. TAKEYAMA K, JUNG B, SHIM JJ, BURGEL PR, DAO-PICK T, UEKI IF, PROTIN U, KROSCHEL P, NADEL JA. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol-Lung Cell Mol Physiol 2001; 280: L165.
33. PRIETO A, REYES E, BERNSTEIN ED, MARTINEZ B, MONSERRAT J, IZQUIERDO JL, CALLOL L, DE LUCAS P, ALVAREZSALA R, ALVAREZ-SALA JL. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferon. Am J Resp Crit Care Med 2001; 163: 1578.
34. FAIRCLOUGH L, URBANOWICZ R, CORNE J, LAMB J. Killer cells in chronic obstructive pulmonary disease. Clin Sci 2008; 114: 533-541.
35. DEMEDTS IK, DEMOOR T, BRACKE KR, JOOS GF, BRUSSELLE GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 7: 53.
36. PARK JW, RYTER SW, CHOI AMK. Functional significance of apoptosis in chronic obstructive pulmonary disease. COPD: J Chron Obstruct Pulmon Dis 2007; 4: 347-353.
37. PANINA P, MARIANI M, DAMBROSIO D. Chemokine receptors in chronic obstructive pulmonary disease (COPD). Curr Drug Targets 2006; 7: 669-674.
38. SAETTA M, MARIANI M, PANINA-BORDIGNON P, TURATO G, BUONSANTI C, BARALDO S, BELLETTATO CM, PAPI A, CORBETTA L, ZUIN R. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2002; 165: 1404-1409.